401 related articles for article (PubMed ID: 1373551)
1. Monoclonal IgM antibodies from cytomegalovirus-infected mice recognize the GlcNAc-containing receptor determinant of murine CMV as well as neutralizing anti-CMV IgG antibodies.
Ravindranath RM; Graves MC
Virology; 1992 May; 188(1):143-51. PubMed ID: 1373551
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
Lawson CM; Grundy JE; Shellam GR
J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
Margaritte C; Gilbert D; Brard F; Tron F
J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
[TBL] [Abstract][Full Text] [Related]
4. Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies.
Farrell HE; Shellam GR
J Gen Virol; 1991 Jan; 72 ( Pt 1)():149-56. PubMed ID: 1846643
[TBL] [Abstract][Full Text] [Related]
5. Characterization of neutralizing monoclonal antibodies to murine cytomegalovirus.
Farrell HE; Shellam GR
J Gen Virol; 1990 Mar; 71 ( Pt 3)():655-64. PubMed ID: 2155998
[TBL] [Abstract][Full Text] [Related]
6. Elimination of nonspecific cytomegalovirus immunoglobulin M activities in the enzyme-linked immunosorbent assay by using anti-human immunoglobulin G.
Joassin L; Reginster M
J Clin Microbiol; 1986 Mar; 23(3):576-81. PubMed ID: 3007570
[TBL] [Abstract][Full Text] [Related]
7. An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency.
Shen C; Zhang M; Chen Y; Zhang L; Wang G; Chen J; Chen S; Li Z; Wei F; Chen J; Yang K; Guo S; Wang Y; Zheng Q; Yu H; Luo W; Zhang J; Chen H; Chen Y; Xia N
Theranostics; 2019; 9(1):210-231. PubMed ID: 30662563
[TBL] [Abstract][Full Text] [Related]
8. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
[TBL] [Abstract][Full Text] [Related]
9. Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus.
Rasmussen L; Kelsall D; Nelson R; Carney W; Hirsch M; Winston D; Preiksaitis J; Merigan TC
J Infect Dis; 1982 Feb; 145(2):191-9. PubMed ID: 6274969
[TBL] [Abstract][Full Text] [Related]
10. Viral Persistence Induces Antibody Inflation without Altering Antibody Avidity.
Welten SPM; Redeker A; Toes REM; Arens R
J Virol; 2016 May; 90(9):4402-4411. PubMed ID: 26889035
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal anti-equine IgE antibodies with specificity for different epitopes on the immunoglobulin heavy chain of native IgE.
Wagner B; Radbruch A; Rohwer J; Leibold W
Vet Immunol Immunopathol; 2003 Mar; 92(1-2):45-60. PubMed ID: 12628763
[TBL] [Abstract][Full Text] [Related]
12. Induction, via immunization with a monoclonal antiidiotypic antibody, of viral envelope specific Ab3 antisera that neutralize retrovirus infectivity.
Rich RF; Mayes BE; Abate MI; Green WR
Viral Immunol; 1993; 6(3):193-206. PubMed ID: 7507328
[TBL] [Abstract][Full Text] [Related]
13. Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus.
Bootz A; Karbach A; Spindler J; Kropff B; Reuter N; Sticht H; Winkler TH; Britt WJ; Mach M
PLoS Pathog; 2017 Aug; 13(8):e1006601. PubMed ID: 28854233
[TBL] [Abstract][Full Text] [Related]
14. Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection.
Basson J; Tardy JC; Aymard M
Arch Virol; 1989; 108(3-4):259-70. PubMed ID: 2557810
[TBL] [Abstract][Full Text] [Related]
15. Anti-idiotypic antibodies to a polyomavirus monoclonal antibody recognize cell surface components of mouse kidney cells and prevent polyomavirus infection.
Marriott SJ; Roeder DJ; Consigli RA
J Virol; 1987 Sep; 61(9):2747-53. PubMed ID: 3039167
[TBL] [Abstract][Full Text] [Related]
16. Murine cytomegalovirus infection model in Balb/c mice. 3. Immunoglobulin production during infection.
Leung WC; Hashimoto K; Umehara K; Hata J
Tokai J Exp Clin Med; 1991 Mar; 16(1):11-20. PubMed ID: 1664146
[TBL] [Abstract][Full Text] [Related]
17. Syngeneic monoclonal anti-idiotype antibodies that bear the internal image of a human cytomegalovirus neutralization epitope.
Keay S; Rasmussen L; Merigan TC
J Immunol; 1988 Feb; 140(3):944-8. PubMed ID: 2448380
[TBL] [Abstract][Full Text] [Related]
18. Properties of IgG subclasses to human cytomegalovirus.
Gilljam G; Wahren B
J Virol Methods; 1989 Aug; 25(2):139-51. PubMed ID: 2550502
[TBL] [Abstract][Full Text] [Related]
19. Development of second generation monoclonal antibodies recognising Lewisy/b antigen by anti-idiotypic immunisation.
Durrant LG; Singhal A; Jacobs E; Price MR
Hybridoma; 1993 Dec; 12(6):647-60. PubMed ID: 7507082
[TBL] [Abstract][Full Text] [Related]
20. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities.
Gupta CK; Leszczynski J; Gupta RK; Siber GR
Biologicals; 1996 Jun; 24(2):117-24. PubMed ID: 8889058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
